93 related articles for article (PubMed ID: 36889492)
1. New Drugs Approved in 2022.
Ebied AM; Elmariah H; Cooper-DeHoff RM
Am J Med; 2023 Jun; 136(6):545-550. PubMed ID: 36889492
[TBL] [Abstract][Full Text] [Related]
2. Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study.
Kesselheim AS; Wang B; Franklin JM; Darrow JJ
BMJ; 2015 Sep; 351():h4633. PubMed ID: 26400751
[TBL] [Abstract][Full Text] [Related]
3. Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care.
Dhruva SS; Darrow JJ; Kesselheim AS; Redberg RF
J Gen Intern Med; 2022 Dec; 37(16):4176-4182. PubMed ID: 35138547
[TBL] [Abstract][Full Text] [Related]
4. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022.
Kayki-Mutlu G; Aksoyalp ZS; Wojnowski L; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1619-1632. PubMed ID: 36951997
[TBL] [Abstract][Full Text] [Related]
5. 2023 in review: FDA approvals of new medicines.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2024 May; 29(5):103966. PubMed ID: 38552777
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and clinical application of new drugs approved by FDA in 2023.
Wang YT; Yang PC; Zhang YF; Sun JF
Eur J Med Chem; 2024 Feb; 265():116124. PubMed ID: 38183778
[TBL] [Abstract][Full Text] [Related]
7. Recent and anticipated novel drug approvals for 2023 and 2024.
Rim MH; Barada F; Levitsky AM
Am J Health Syst Pharm; 2023 Nov; 80(23):1729-1732. PubMed ID: 37688502
[TBL] [Abstract][Full Text] [Related]
8. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023.
Kayki-Mutlu G; Aksoyalp ZS; Wojnowski L; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2949-2970. PubMed ID: 38530400
[TBL] [Abstract][Full Text] [Related]
9. Great Trees Require Strong Roots: Evaluating Data and Delegation Doctrine Underlying Proposed Reforms to FDA's Accelerated Approval Program.
Deshmukh AD
J Law Med Ethics; 2023; 51(4):920-925. PubMed ID: 38477271
[TBL] [Abstract][Full Text] [Related]
10. Recent and anticipated novel drug approvals for 2024.
Rim MH; Karas BL; Barada F; Levitsky AM
Am J Health Syst Pharm; 2024 May; 81(10):385-389. PubMed ID: 38373160
[TBL] [Abstract][Full Text] [Related]
11. Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022.
Gu M; Sun S; You Q; Wang L
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138431
[TBL] [Abstract][Full Text] [Related]
12. Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
Papapetropoulos A; Topouzis S; Alexander SPH; Cortese-Krott M; Kendall DA; Martemyanov KA; Mauro C; Nagercoil N; Panettieri RA; Patel HH; Schulz R; Stefanska B; Stephens GJ; Teixeira MM; Vergnolle N; Wang X; Ferdinandy P
Br J Pharmacol; 2024 Jun; 181(11):1553-1575. PubMed ID: 38519837
[TBL] [Abstract][Full Text] [Related]
13. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021.
Kayki-Mutlu G; Aksoyalp ZS; Wojnowski L; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):867-885. PubMed ID: 35543739
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule.
Temrikar ZH; Golden JE; Jonsson CB; Meibohm B
Clin Pharmacokinet; 2023 Jul; 62(7):943-953. PubMed ID: 37326917
[TBL] [Abstract][Full Text] [Related]
15. FDA review times for new drugs in ophthalmology.
Carpenter MA; Novack GD
Ocul Surf; 2020 Oct; 18(4):963-966. PubMed ID: 32795591
[No Abstract] [Full Text] [Related]
16. Study bolsters concerns about US FDA accelerated drug approvals.
Furlow B
Lancet Oncol; 2024 May; 25(5):543. PubMed ID: 38621403
[No Abstract] [Full Text] [Related]
17. DrugCentral: online drug compendium.
Ursu O; Holmes J; Knockel J; Bologa CG; Yang JJ; Mathias SL; Nelson SJ; Oprea TI
Nucleic Acids Res; 2017 Jan; 45(D1):D932-D939. PubMed ID: 27789690
[TBL] [Abstract][Full Text] [Related]
18. Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
Ali S; Bolinger AA; Zhou J
Curr Top Med Chem; 2024; 24(10):843-849. PubMed ID: 38445700
[TBL] [Abstract][Full Text] [Related]
19. 2023 FDA-approved psychotropic medications.
Naguy A; Alayadhi N; Pridmore S; Alhazeem H; Alamiri B
Asian J Psychiatr; 2023 Sep; 87():103684. PubMed ID: 37379646
[TBL] [Abstract][Full Text] [Related]
20. A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs.
Brown DG
J Med Chem; 2024 Feb; 67(3):1690-1700. PubMed ID: 38233132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
